Sort
17,288 grants matching “multiple sclerosis”
University of Chicago Autoimmunity Center of Excellence
$656,684Marcus R Clark · University Of Chicago · U19 · FY2012 · AI
AUTOIMMUNITY: TREATMENT BY COSTIMULATORY SIGNAL BLOCKADE
$656,642Brigham And Women'S Hospital · U19 · FY2000 · AI
SCH: INT: Collaborative Research: High-throughput Phenotyping on Electronic Health Records using Multi-Tensor Factorization
$656,617Chao Zhang · Georgia Tech Research Corporation · · FY2014 · CSE
Development and Validation of a Self-Efficacy Item Bank
$656,398Lisa M. Shulman · University Of Maryland Baltimore · U01 · FY2009 · AR
ANTIGEN PRESENTATION IN HUMAN AUTOIMMUNE DISEASES
$655,979Dana-Farber Cancer Institute · P01 · FY2000 · AI
Long-term reliable neuroprosthetic control of a robotic arm and hand using electrocorticography.
$655,924Karunesh Ganguly · University Of California, San Francisco · R01 · FY2024 · HD
Long-term reliable neuroprosthetic control of a robotic arm and hand using electrocorticography.
$655,924Karunesh Ganguly · University Of California, San Francisco · R01 · FY2025 · HD
Assessment of Ultrsound-facilitated Neurotherapeutics in Alzheimer's Disease
$655,815Elisa E Konofagou · Columbia University Health Sciences · R01 · FY2019 · AG
T Cell Alternative p38 Activation Pathway
$655,729Jonathan Ashwell · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Decoding and targeting the PI3K-mTOR signaling network in cancer
$655,619Brendan D. Manning · Harvard School Of Public Health · R35 · FY2015 · CA
Contribution of plasmablasts in the conversion of transverse myelitis to multiple sclerosis
$655,492Nancy L Monson · Ut Southwestern Medical Center · R01 · FY2022 · NS
Autoimmunity Center of Excellence - Rochester
$655,483R John Looney · University Of Rochester · U19 · FY2012 · AI
Inhibition of the Rho/MRTF/SRF Pathway as a New Treatment for Systemic Sclerosis
$655,452Scott D Larsen · University Of Michigan At Ann Arbor · R01 · FY2014 · AR
Translational refinement of adaptive communication system for locked-in patients
$655,370Melanie Beth Fried-Oken · Oregon Health & Science University · R01 · FY2013 · DC
Mediators and Moderators of Executive Function Training in Older Adults
$655,325Susanne M Jaeggi · Northeastern University · R01 · FY2025 · AG
Unraveling the Superficial White Matter of the Primate Brain: Tracer-Based Histology and dMRI Tractography Validation
$655,055Richard J Rushmore · Boston University Medical Campus · R01 · FY2024 · NS
In vivo assessment of meningeal inflammation and its clinical impact in multiple sclerosis by 7 Tesla MRI
$655,017Daniel M Harrison · University Of Maryland Baltimore · R01 · FY2018 · NS
Defining mechanisms underlying C9orf72-associated frontotemporal dementia with C. elegans and mammalian models
$654,898Robert G Kalb · Northwestern University At Chicago · R01 · FY2025 · NS
SUSCEPTIBILITY AND RESISTANCE LOCI IN MOUSE EAE
$654,595University Of Vermont &St Agric College · R01 · FY2003 · NS
Evaluating the therapeutic potential of hypoxia mimetics in inflammatory demyelinating disease
$654,426D. Richard Milner · San Diego Biomedical Research Institute · R01 · FY2025 · NS
Computational Model of Neurocognitive Impairment in Multiple Sclerosis
$654,287James Francis Sumowski · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · NS
Molecular Epidemiology of EBV and Multiple Sclerosis
$654,161Harvard University (Sch Of Public Hlth) · R01 · FY2005 · NS
MRI predictors of disease and disability progression in African Americans with multiple sclerosis
$653,611Fred D Lublin · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · NS
TNFAIP3 (A20) and Susceptibility to Systemic Lupus Erythematosus
$653,597Patrick M Gaffney · Oklahoma Medical Research Foundation · R01 · FY2018 · AR
TNFAIP3 (A20) and Susceptibility to Systemic Lupus Erythematosus
$653,597Patrick M Gaffney · Oklahoma Medical Research Foundation · R01 · FY2015 · AR